![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Sunday, January 30, 2022 9:33:39 AM
"The FDA is working with Empowered Diagnostics to resolve these issues. "
Kaptain,
Those are my thoughts exactly.
AXIM was still advertising ImmunoPass on Facebook and LinkedIn with no mention of the recall issued by Empowered Diagnostics.
Meanwhile investors are watching their investment tank from $0.49 down to $0.19 on Friday. Now with the FDA release we might see single digits before this slide is over.
How is that not fraud?
In addition to that, cheap shares are the worst thing that can happen to a small company with no cashflow.
Now labor and raw materials and services like accounting and advertising all cost a lot more shares than than they did just a month ago. Can AXIM even generate enough cash to roll out the Dry Eye Disease segment now? Was Mr Huemoeller able to sell shares at $0.49 to pay for the DED roll out?
All if this stinks.
Why did Sapphire Biotech ever think it was a good idea to be bought out by MJNA leadership??
On the other hand I have always wanted to believe in Empowered Diagnostics and their leadership and yet they are the ones being called out by the FDA at this time. I just don't know if I can agree about a wink wink nod nod agreement with the FDA. However. We do have this interesting comment hidden within the FDA recall warning:
"The FDA is working with Empowered Diagnostics to resolve these issues. "
Maybe I should copy this sentence to the top so my post is not such a downer.
Recent AXIM News
- Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend] • Edgar (US Regulatory) • 05/22/2024 08:53:56 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/20/2024 08:24:40 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/28/2023 04:59:09 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/20/2023 09:29:50 PM
- Form DEF 14C - Other definitive information statements • Edgar (US Regulatory) • 09/21/2023 03:07:21 PM
- Form PRE 14C - Other preliminary information statements • Edgar (US Regulatory) • 08/31/2023 08:10:23 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/21/2023 05:35:50 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 08/14/2023 08:11:37 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM
North Bay Resources Announces Successful Flotation Cell Test at Bishop Gold Mill, Inyo County, California • NBRI • Jun 27, 2024 9:00 AM
Branded Legacy, Inc. and Hemp Emu Announce Strategic Partnership to Enhance CBD Product Manufacturing • BLEG • Jun 27, 2024 8:30 AM
POET Wins "Best Optical AI Solution" in 2024 AI Breakthrough Awards Program • POET • Jun 26, 2024 10:09 AM
HealthLynked Promotes Bill Crupi to Chief Operating Officer • HLYK • Jun 26, 2024 8:00 AM